The PD-1/PD-L1 pathway plays a critical role in maintaining immune tolerance and preventing autoimmunity. However, in the context of cancer, its dysregulation by tumors creates a major hurdle for the immune system to eliminate cancer cells. By blocking the PD-1/PD-L1 interaction, we can reinvigorate T cell responses and unleash their antitumor potential. The treatment landscape […]
